Skip to main content
. 2000 Dec 1;20(23):8701–8709. doi: 10.1523/JNEUROSCI.20-23-08701.2000

Fig. 4.

Fig. 4.

SL 327, an inhibitor of ERK activation, partially inhibits cocaine-induced hyperlocomotion. SL 327 (50 mg/kg, i.p.) was injected 1 hr before cocaine. A, Note the total inhibition of cocaine-induced P-ERK immunoreactivity by SL 327. B, Effect of SL 327 on cocaine-induced hyperlocomotion (n = 8 mice for each group). Statistical comparisons were performed as described Figure 2.